ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,918Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 551

$587K Total Retail Price of All Prescriptions

Rank: 62 out of 551

624 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 624 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

3% of this provider’s 624 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 11,325 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
OMEPRAZOLE 802 461 1 7
SYNTHROID 719 426 2 11
RANITIDINE HCL 646 397 3 8
AMLODIPINE BESYLATE 622 484 4 4
METFORMIN HCL 565 425 5 2
SIMVASTATIN 556 402 6 1
LOSARTAN POTASSIUM 519 352 7 6
GABAPENTIN 515 321 8 3
ENALAPRIL MALEATE 422 278 9 5
LEVOTHYROXINE SODIUM 414 309 10 9
DICLOFENAC POTASSIUM 346 181 11 45
TRAMADOL HCL 313 183 12 32
INSULIN SYRINGE 296 219 13 41
ATENOLOL 295 155 14 12
FLUTICASONE PROPIONATE 294 102 15 66
LOSARTAN-HYDROCHLOROTHIAZIDE 286 218 16 10
HUMULIN N 282 182 17 47
TRAMADOL HCL-ACETAMINOPHEN 252 146 18 18
ZOLPIDEM TARTRATE 244 138 19 27
GLIMEPIRIDE 232 187 20 16
PRAVASTATIN SODIUM 226 200 21 24
FUROSEMIDE 203 158 22 13
METOPROLOL TARTRATE 194 165 23 17
CARVEDILOL 194 177 23 22
CLOTRIMAZOLE-BETAMETHASONE 182 98 25 49
RAMIPRIL 140 92 26 53
HYDROCHLOROTHIAZIDE 140 111 26 15
QVAR 137 68 28 136
HUMULIN 70-30 133 104 29 35
DOXAZOSIN MESYLATE 130 89 30 25
AZITHROMYCIN 129 79 31 55
SULINDAC 125 65 32 78
FAMOTIDINE 124 92 33 31
ASPIRIN EC 116 100 34 26
FLUOXETINE HCL 115 52 35 93
AMLODIPINE BESYLATE-BENAZEPRIL 114 72 36 42
DIOVAN 110 85 37 57
SINGULAIR 108 24 38 58
IRBESARTAN 107 99 39 51
MECLIZINE HCL 105 86 40 56
NABUMETONE 104 43 41 37
CLOBETASOL PROPIONATE 103 55 42 177
CEFUROXIME 100 51 43 198
ADVAIR DISKUS 96 31 44 97
VERAPAMIL ER 94 67 45 39
PLAVIX 93 74 46 33
CARAFATE 93 44 46 130
SERTRALINE HCL 92 65 48 43
EVISTA 92 82 48 52
AMITRIPTYLINE HCL 92 27 R 48 96
PANTOPRAZOLE SODIUM 91 29 51 36
ALENDRONATE SODIUM 89 69 52 19
ISOSORBIDE MONONITRATE ER 89 75 52 21
HUMULIN R 87 65 54 161
CIPROFLOXACIN HCL 86 52 55 54
CLOPIDOGREL 86 77 55 30
GEMFIBROZIL 84 43 57 61
ALLOPURINOL 83 46 58 84
METOPROLOL SUCCINATE 73 53 59 23
DIGOXIN 73 73 59 44
LEVOXYL 70 45 61 40
LANTUS 69 32 62 28
CLONIDINE HCL 62 38 63 60
CEFADROXIL 62 41 63 153
AVAPRO 61 50 65 83
GLIPIZIDE 61 46 65 20
GLYBURIDE-METFORMIN HCL 60 48 R 67 48
SUCRALFATE 57 22 68 120
KETOROLAC TROMETHAMINE 57 12 R 68 288
PROAIR HFA 55 15 70 92
LANSOPRAZOLE 55 34 70 72
CYMBALTA 55 0 70 105
NAPROXEN 54 40 73 80
HYDROCODONE-ACETAMINOPHEN 53 0 S3 74 167
ORPHENADRINE CITRATE 51 0 R 75 147
DONEPEZIL HCL 51 51 75 50
CETIRIZINE HCL 50 26 77 154
NAPROXEN SODIUM 50 14 77 137
OXYCODONE-ACETAMINOPHEN 50 0 S2 77 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.